GRAIL
The Post‑Analytical Review Scientist at Grail will perform comprehensive review of clinical laboratory data generated from high‑throughput genomics workflows, ensuring data quality, regulatory compliance, and accurate report release. The role involves evaluating sequencing metrics, documenting findings, and collaborating with laboratory, bioinformatics, and quality teams to support high‑volume testing operations.
GRAIL is a healthcare company pioneering new technologies to advance early cancer detection. The company offers the Galleri® Test, a multi-cancer early detection (MCED) blood test capable of screening for signals from more than 50 types of cancer, including those without existing routine screening options. GRAIL operates in the healthcare and oncology industry with a mission to detect cancer early, when it can be cured.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GRAIL.
GRAIL didn’t post a salary, so this is our estimate from similar listings.
3% above the average for this role
Post-Doctoral Research Fellow in Cancer Genomics, Precision Oncology, and Liquid Biopsy
Thomas Jefferson University
Associate Scientist I
Integrated Resources INC
Clinical Genomic Scientist
Baylor Genetics
Associate Scientist I
Integrated Resources INC
Clinical Genomics Scientist
Baylor Genetics
Medical Scientist Grade 2
Peter MacCallum Cancer Centre